Scale Cell & Gene Therapy Access for Stronger Launch (Broadcast 2)
About this webinar
The future of cell and gene therapy will be shaped not only by clinical breakthroughs but also by the industry’s ability to connect patients, providers, payers and support services in an increasingly complex treatment environment. This webinar explores the commercialization considerations that can help manufacturers strengthen launch readiness, coordinate patient support and scale access while preserving the specialized care advanced therapies require.
As more advanced therapies move toward commercialization, manufacturers face critical decisions that can influence launch readiness and long-term adoption. The featured speakers will discuss key considerations including distribution strategy, site readiness, patient identification, reimbursement challenges and ongoing patient support.
The speakers will discuss how organizations can build scalable, coordinated models that expand access while maintaining the specialized capabilities advanced therapies require and how commercialization planning is increasingly becoming a competitive advantage long before launch.
Register for this webinar to gain insight into how cell & gene therapy commercialization decisions can influence launch readiness, patient access and long-term adoption of advanced therapies.
3-part Cell & Gene Therapy Webinar Series:
- Part 1: Improve Cell & Gene Therapy Access Readiness as Pipelines Evolve
- Part 2: Expanding Cell & Gene Therapy Access Requires More Than Science
- Part 3: (Register below) Scale Cell & Gene Therapy Access for Stronger Launch Readiness
Who should attend
- Cell and Gene Therapy Manufacturers
- Commercialization and Market Access Leaders
- Patient Services and Medical Affairs Professionals
- Provider and Specialty Pharmacy Partners
- Consultants and Advisors supporting CGT programs
What you will learn
- Common commercialization challenges across advanced therapies
- Critical pre-launch considerations for access and adoption
- Strategies for navigating reimbursement, coordination and patient support
- Approaches for scaling access while preserving specialized care
Featured Speakers
Kim Tedesco
Kim Tedesco, RPh, is the Director of Gene & Cell Therapy Pharmacy Operations at Walgreens Gene & Cell Services Pharmacy. She is a pharmacy leader dedicated to advancing pharmacy practice.
In her current role, Kim leads the strategic direction of the gene and cell pharmacy at Walgreens to create a center of excellence dedicated to gene and cell therapies. She works to overcome barriers and help ensure these new-to-market therapies reach the intended patients.
Kim has previous experience in retail, pharmaceutical sales, operations and specialty pharmacy. She is a licensed Pharmacist in 26 states and attended Duquesne University School of Pharmacy in Pittsburgh, Pennsylvania.
Noel Toonder
Noel Toonder is Head of BioPharma and Specialty Trade at Walgreens, where he leads strategy across biopharma, specialty and advanced therapies. He brings more than 25 years of experience in market access, reimbursement, distribution and patient services for complex medical-benefit therapies, with a decade focused on advanced therapies and cell and gene therapy.
Before joining Walgreens, Noel held senior leadership roles across biotechnology and advanced therapy companies, including Rocket Pharmaceuticals and Atara Biotherapeutics. His experience includes building global distribution, reimbursement and patient-support models for autologous and allogeneic therapies, including commercialization infrastructure designed to move highly complex treatments from development to real-world patient access.
Partner for this event
Walgreens
Founded in 1901, Walgreens (www.walgreens.com) proudly serves more than 9 million customers and patients each day across its nearly 8,000 stores throughout the U.S. and Puerto Rico. Walgreens has approximately 211,000 team members, including roughly 85,000 healthcare service providers, and is committed to being the first choice for pharmacy, retail and health services, building trusted relationships that create healthier futures for customers, patients, team members and communities.